130.16
-2.36
(-1.78%)
At close: 5:32:09 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 11 | 11 |
| Avg. Estimate | 29.34B | 30.54B | 122.49B | 122.94B |
| Low Estimate | 26.29B | 27.07B | 104.24B | 92.3B |
| High Estimate | 31.56B | 35.67B | 140.96B | 176.59B |
| Year Ago Sales | 31.76B | 34.49B | 129.88B | 122.49B |
| Sales Growth (year/est) | -7.63% | -11.45% | -5.69% | 0.37% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| VLO.VI | -- | -- | -- | -- |
| S&P 500 | 9.01% | 10.57% | 14.00% | 13.70% |
Upgrades & Downgrades
| Maintains | Mizuho: Outperform to Outperform | 1/8/2025 |
| Maintains | Mizuho: Outperform to Outperform | 12/16/2024 |
| Maintains | Wells Fargo: Overweight to Overweight | 12/9/2024 |
| Maintains | Barclays: Overweight to Overweight | 11/11/2024 |
| Maintains | TD Cowen: Buy to Buy | 10/25/2024 |
| Maintains | Citigroup: Buy to Buy | 10/25/2024 |